0000899243-22-039412.txt : 20221227 0000899243-22-039412.hdr.sgml : 20221227 20221227183449 ACCESSION NUMBER: 0000899243-22-039412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221222 FILED AS OF DATE: 20221227 DATE AS OF CHANGE: 20221227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Korenberg Matthew E CENTRAL INDEX KEY: 0001649903 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 221491350 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-22 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001649903 Korenberg Matthew E 3911 SORRENTO VALLEY BOULEVARD, SUITE 110 SAN DIEGO CA 92121 0 1 0 0 President & COO Employee Stock Option (right to buy) 67.03 2022-12-22 4 A 0 25967 0.00 A 2032-12-22 Common Stock 25967 25967 D Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter. /s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg 2022-12-27